Autoimmune & Inflammatory
Also called GCA, Temporal Arteritis, Cranial Arteritis
Giant Cell Arteritis is a systemic vasculitis affecting large and medium-sized arteries, with primary involvement of the external carotid artery system and its branches, particularly the temporal artery. The disease results from T cell-mediated granulomatous inflammation with characteristic giant cells and macrophage infiltration of the vessel wall.
Giant Cell Arteritis predominantly affects people over 50 years old, with median age of onset around 70-75 years. It affects females slightly more than males. The disease is much more common in people of Northern European descent (particularly Scandinavian, British, and Northern European ancestry) and rare in African, Native American, and Asian populations. About 40-60% of GCA patients have concurrent polymyalgia rheumatica.
Clinical trials for Giant Cell Arteritis focus on corticosteroid-sparing strategies and newer biologic therapies, particularly TNF inhibitors and IL-6 inhibitors (tocilizumab), which have shown promise in clinical trials. Trials investigate optimal induction and maintenance therapy with goal of minimizing corticosteroid exposure while preventing relapses and ischemic complications. Management requires urgent diagnosis and treatment initiation to prevent vision loss. Patients should consult with a rheumatologist experienced in vasculitis.
Takayasu Arteritis is a rare chronic inflammatory disease of large arteries, particularly the aorta and its branches, ca...
Granulomatosis with Polyangiitis is a rare autoimmune disease causing inflammation of small and medium blood vessels in ...
Behçet Disease is a rare, chronic, recurrent vasculitis causing painful oral and genital ulcers, eye inflammation, and s...